Bumper Offer - Urjas oil Just @ Rs. 1
Lidogab is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Lidogab is used -
Severe
Moderate
Mild
Common
Is the use of Lidogab safe for pregnant women?
Lidogab has little to no side effects in pregnant women.
Is the use of Lidogab safe during breastfeeding?
Side effects of Lidogab on breastfeeding women are very mild.
What is the effect of Lidogab on the Kidneys?
Lidogab rarely affects the kidneys.
What is the effect of Lidogab on the Liver?
Side effects of Lidogab rarely affect the liver.
What is the effect of Lidogab on the Heart?
Lidogab is rarely harmful for the heart.
Lidogab should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lidogab unless your doctor advises you to do so -
Is this Lidogab habit forming or addictive?
Lidogab is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Lidogab can make you feel drowsy.
Is it safe?
Lidogab should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Lidogab in mental disorders is not effective.
Interaction between Food and Lidogab
Lidogab may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Lidogab
Due to lack of research, there is no information about the side effects of taking Lidogab with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
